Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study

We did not observe a survival benefit among HSCT patients compared to non-HSCT patients within the RELCP cohort. This could be due to patients having received a mean of 6.3 lines of treatment before HSCT. Larger studies might help identify subgroups of patients who might benefit from HSCT.

Authors

Institutions

Publication Details

Journal
Journal of the European Academy of Dermatology and Venereology
Published
2025-03-11
DOI
https://doi.org/10.1111/jdv.20638
Citations
1
Primary Topic
Cutaneous lymphoproliferative disorders research
Type
article
Field-Weighted Citation Impact
2.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study

Rafael Botella‐Estrada, Helena Iznardo, Lucía Prieto‐Torres, Carlos Moreno‐Vílchez et al.
1 citations
Journal of the European Academy of Dermatology and Venereology
Cutaneous lymphoproliferative disorders research
2.00
article

Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study

Rafael Botella‐Estrada, Helena Iznardo, Lucía Prieto‐Torres, Carlos Moreno‐Vílchez, Elena Amutio Díez, Lía Bejarano, Pablo L. Ortiz‐Romero, Mercè Grau‐Pérez, Yeray Peñate, I. García‐Doval, Cristina Muniesa Montserrat, C. Martínez-Mera, Javier Cañueto, Octavio Servitje, Juan Torre‐Castro, Ricardo Fernández‐de‐Misa, Mercedes Morillo, María Elisabet Parera Amer, Maria Pilar García Muret, M. Blanes, M. Teresa Estrach, R.M Belloso, Miren Josune Michelena Eceiza, Marina Paíno‐Román
article en
1 citations

Abstract

We did not observe a survival benefit among HSCT patients compared to non-HSCT patients within the RELCP cohort. This could be due to patients having received a mean of 6.3 lines of treatment before HSCT. Larger studies might help identify subgroups of patients who might benefit from HSCT.

Journal of the European Academy of Dermatology and VenereologyVol. 40(1)
Hospital Universitario Insular de Gran Canaria (ES), Hospital de Sant Pau (ES), Bellvitge University Hospital (ES), Hospital Son Llatzer (ES), Hospital Universitario Nuestra Señora de Candelaria (ES), Hospital de Basurto (ES), Complejo Hospitalario de Navarra (ES), Complejo Hospitalario de Salamanca (ES), Hospital Universitario 12 De Octubre (ES), Spanish Academy of Dermatology and Venereology (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Hospital Universitario Fundación Jiménez Díaz (ES), Instituto de Investigación Biomédica de Salamanca (ES), Hospital Clínico Universitario Lozano Blesa (ES), Hospital de Cruces (ES), Hospital General Universitario de Alicante Doctor Balmis (ES), Hospital Universitario Virgen del Rocío (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Instituto de Investigación Sanitaria La Fe (ES), Universitat de Barcelona (ES)
No poverty
Openalex Percentile: Top 17%
Cutaneous lymphoproliferative disorders research
2.00
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.